By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Cambridge Laboratories Limited 

Deltic House
Kingfisher Way

Silverlink Business Park
Tyne & Wear    NE28 9NX  United Kingdom
Phone: 44-0-191-296-9369 Fax: 44-0-191-296-9368



Company News
Cambridge Laboratories Limited Announces Approval of Tetrabenazine in Spain 12/8/2008 7:08:47 AM
Cambridge Laboratories Limited Announces Launch Of XENAZINE(R) (Tetrabenazine) In The US 12/1/2008 3:35:36 PM
Cambridge Laboratories Limited Announces New Marketing Arrangements for XENAZINE® in North America 9/25/2008 4:40:10 PM
Cambridge Laboratories Limited Appoints Peter Butterfield as UK Commercial Manager 9/13/2007 3:34:27 PM
Valeant Pharmaceuticals International (VRX) Acquires Rights To Nabilone In United Kingdom And Europe From Cambridge Laboratories Limited; $14 Million 2/16/2007 12:37:49 PM
Cambridge Laboratories Limited's XENAZINE® 25 Mg Launched In France 8/25/2006 10:38:15 AM
Cambridge Laboratories Limited Announces CHMP Positive Opinion For Valtropin(TM) 2/24/2006 3:11:29 PM
Prestwick Pharmaceuticals, Inc. Release: Study Published In Neurology Shows Tetrabenazine Significantly Improves Debilitating Movement Disorder Caused By Huntington's Disease 2/14/2006 12:59:28 PM
Prestwick Pharmaceuticals, Inc. Acquires Rights To Commercialize Nitoman (Tetrabenazine) In Canada10/19/2005 5:11:29 PM
IDM And Cambridge Laboratories Limited Sign An Exclusive Marketing Agreement For Junovan(TM) (Mepact) In The United Kingdom And Ireland10/19/2005 5:09:19 PM